vs
MongoDB, Inc.（MDB）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
MongoDB, Inc.的季度营收约是Royalty Pharma plc的1.0倍（$628.3M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs -0.3%，领先34.8%），MongoDB, Inc.同比增速更快（18.7% vs 4.8%），过去两年MongoDB, Inc.的营收复合增速更高（17.1% vs 4.6%）
MongoDB Inc.是美国软件企业，核心业务为开发面向非结构化数据的数据库引擎MongoDB并提供相关商用技术支持。该产品脱胎于NoSQL数据库，后续新增ACID事务等能力，功能覆盖场景持续拓展，可充分满足全球企业级客户的多元需求。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
MDB vs RPRX — 直观对比
营收规模更大
MDB
是对方的1.0倍
$622.0M
营收增速更快
MDB
高出13.9%
4.8%
净利率更高
RPRX
高出34.8%
-0.3%
两年增速更快
MDB
近两年复合增速
4.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $628.3M | $622.0M |
| 净利润 | $-2.0M | $214.2M |
| 毛利率 | 71.5% | — |
| 营业利润率 | -2.9% | 62.4% |
| 净利率 | -0.3% | 34.4% |
| 营收同比 | 18.7% | 4.8% |
| 净利润同比 | 79.5% | 2.9% |
| 每股收益（稀释后） | — | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDBRPRX
| Q4 25 | $628.3M | $622.0M | ||
| Q3 25 | $591.4M | $609.3M | ||
| Q2 25 | $549.0M | $578.7M | ||
| Q1 25 | $548.4M | $568.2M | ||
| Q4 24 | $529.4M | $593.6M | ||
| Q3 24 | $478.1M | $564.7M | ||
| Q2 24 | $450.6M | $537.3M | ||
| Q1 24 | $458.0M | $568.0M |
净利润MDBRPRX
| Q4 25 | $-2.0M | $214.2M | ||
| Q3 25 | $-47.0M | $288.2M | ||
| Q2 25 | $-37.6M | $30.2M | ||
| Q1 25 | $15.8M | $238.3M | ||
| Q4 24 | $-9.8M | $208.2M | ||
| Q3 24 | $-54.5M | $544.0M | ||
| Q2 24 | $-80.6M | $102.0M | ||
| Q1 24 | $-55.5M | $4.8M |
毛利率MDBRPRX
| Q4 25 | 71.5% | — | ||
| Q3 25 | 71.0% | — | ||
| Q2 25 | 71.2% | — | ||
| Q1 25 | 72.8% | — | ||
| Q4 24 | 74.4% | — | ||
| Q3 24 | 73.2% | — | ||
| Q2 24 | 72.8% | — | ||
| Q1 24 | 75.0% | — |
营业利润率MDBRPRX
| Q4 25 | -2.9% | 62.4% | ||
| Q3 25 | -11.0% | 70.1% | ||
| Q2 25 | -9.8% | 36.3% | ||
| Q1 25 | -3.4% | 94.0% | ||
| Q4 24 | -5.3% | 60.9% | ||
| Q3 24 | -14.9% | — | ||
| Q2 24 | -21.8% | 50.2% | ||
| Q1 24 | -15.5% | -13.0% |
净利率MDBRPRX
| Q4 25 | -0.3% | 34.4% | ||
| Q3 25 | -8.0% | 47.3% | ||
| Q2 25 | -6.9% | 5.2% | ||
| Q1 25 | 2.9% | 41.9% | ||
| Q4 24 | -1.8% | 35.1% | ||
| Q3 24 | -11.4% | 96.3% | ||
| Q2 24 | -17.9% | 19.0% | ||
| Q1 24 | -12.1% | 0.8% |
每股收益（稀释后）MDBRPRX
| Q4 25 | — | $0.49 | ||
| Q3 25 | — | $0.67 | ||
| Q2 25 | — | $0.07 | ||
| Q1 25 | — | $0.55 | ||
| Q4 24 | — | $0.46 | ||
| Q3 24 | — | $1.21 | ||
| Q2 24 | — | $0.23 | ||
| Q1 24 | — | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $834.1M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $2.9B | $9.7B |
| 总资产 | $3.6B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资MDBRPRX
| Q4 25 | $834.1M | $618.7M | ||
| Q3 25 | $647.1M | $938.9M | ||
| Q2 25 | $657.8M | $631.9M | ||
| Q1 25 | $490.1M | $1.1B | ||
| Q4 24 | $673.1M | $929.0M | ||
| Q3 24 | $1.3B | $950.1M | ||
| Q2 24 | $815.7M | $1.8B | ||
| Q1 24 | $803.0M | $843.0M |
总债务MDBRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益MDBRPRX
| Q4 25 | $2.9B | $9.7B | ||
| Q3 25 | $2.9B | $9.6B | ||
| Q2 25 | $3.0B | $9.5B | ||
| Q1 25 | $2.8B | $9.8B | ||
| Q4 24 | $1.5B | $10.3B | ||
| Q3 24 | $1.4B | $10.3B | ||
| Q2 24 | $1.3B | $9.8B | ||
| Q1 24 | $1.1B | $9.9B |
总资产MDBRPRX
| Q4 25 | $3.6B | $19.6B | ||
| Q3 25 | $3.5B | $19.3B | ||
| Q2 25 | $3.6B | $18.3B | ||
| Q1 25 | $3.4B | $17.6B | ||
| Q4 24 | $3.2B | $18.2B | ||
| Q3 24 | $3.1B | $18.0B | ||
| Q2 24 | $3.0B | $17.7B | ||
| Q1 24 | $2.9B | $16.1B |
负债/权益比MDBRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $143.5M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $141.8M | — |
| 自由现金流率自由现金流/营收 | 22.6% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $346.3M | — |
8季度趋势，按日历期对齐
经营现金流MDBRPRX
| Q4 25 | $143.5M | $827.1M | ||
| Q3 25 | $72.1M | $702.6M | ||
| Q2 25 | $109.9M | $364.0M | ||
| Q1 25 | $50.5M | $596.1M | ||
| Q4 24 | $37.4M | $742.5M | ||
| Q3 24 | $-1.4M | $703.6M | ||
| Q2 24 | $63.6M | $658.2M | ||
| Q1 24 | $54.6M | $664.6M |
自由现金流MDBRPRX
| Q4 25 | $141.8M | — | ||
| Q3 25 | $71.6M | — | ||
| Q2 25 | $108.3M | — | ||
| Q1 25 | $24.6M | — | ||
| Q4 24 | $35.5M | — | ||
| Q3 24 | $-2.4M | — | ||
| Q2 24 | $63.1M | — | ||
| Q1 24 | $51.9M | — |
自由现金流率MDBRPRX
| Q4 25 | 22.6% | — | ||
| Q3 25 | 12.1% | — | ||
| Q2 25 | 19.7% | — | ||
| Q1 25 | 4.5% | — | ||
| Q4 24 | 6.7% | — | ||
| Q3 24 | -0.5% | — | ||
| Q2 24 | 14.0% | — | ||
| Q1 24 | 11.3% | — |
资本支出强度MDBRPRX
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.6% | — |
现金转化率MDBRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | 3.19× | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDB
| Mongo DB Atlas Related | $470.4M | 75% |
| Other Subscription | $138.7M | 22% |
| Services | $19.2M | 3% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
